The European Medicines Agency has recommended pan-EU marketing approval for 10 new products, including Qdenga, Takeda Pharmaceutical’s dengue vaccine, which the agency also simultaneously recommended for approval in low- and middle-income non-EU countries.
Qdenga (dengue tetravalent vaccine (live, attenuated)) is for the prevention of dengue virus serotypes 1, 2, 3 and 4 in...